The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 121.59%.However, over the last six months, we can see a weaker performance of 110.29%. Over the last 30 days, the price of LPCN has fallen by 56.12%. And in the last five days, it has surged by 34.11%.
Lipocine Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $6.70 on 04/11/24 and the lowest value was $2.31 on 10/30/23.
52-week price history of LPCN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Lipocine Inc’s current trading price is -7.73% away from its 52-week high, while its distance from the 52-week low is 167.62%. The stock’s price range during this period has varied between$2.31 and $6.70. The Lipocine Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.07 million for the day, a figure considerably higher than their average daily volume of 32159.0 over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Lipocine Inc (LPCN) has experienced a quarterly rise of 99.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.89M and boasts a workforce of 17 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.65, with a change in price of +3.41. Similarly, Lipocine Inc recorded 46,600 in trading volume during the last 100 days, posting a change of +124.91%.
LPCN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LPCN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
LPCN Stock Stochastic Average
Lipocine Inc’s raw stochastic average for the past 50 days is presently 74.43%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 69.82%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 86.33% and 89.67%, respectively.
